Literature DB >> 28609415

Effect of Povidone Iodine 5% on the Cornea, Vision, and Subjective Comfort.

William H Ridder1, Caren Oquindo, Kavita Dhamdhere, James Burke.   

Abstract

PURPOSE: To determine the effects of povidone iodine 5% (Betadine 5%) applied to the eye on visual function, corneal integrity, and subjective complaints.
METHODS: Ten subjects were chosen to participate in this study (average age 40.6 ± 19.6; age range 22-68). LogMAR acuity, contrast sensitivity, corneal fluorescein staining, and subjective complaints were measured before and after 60 μl of Betadine 5% or saline were applied to one eye (eligibility visit, baseline, 5, 30, and 60 minutes and 4 and 24 hours post-application). Contrast sensitivity at 14 cpd was determined with a spatial two-alternative, forced choice procedure (Beethoven software). The National Eye Institute (NEI) grid pattern was used to grade corneal staining with sodium fluorescein. To avoid the detrimental effects of sodium fluorescein administration on functional vision, the corneal staining baseline was measured at the eligibility visit. Subjective complaints were monitored using the Schein dry eye questionnaire.
RESULTS: The data were analyzed with an ANOVA. Saline administration did not alter logMAR acuity, contrast sensitivity, corneal fluorescein staining, or subjective complaints at any visit. Betadine administration significantly reduced the logMAR acuity, compared to baseline and the saline data, at the 30- and 60-minute visits (all P values <.05). The contrast sensitivity was significantly reduced compared to the baseline and the saline results at 5, 30, and 60 minutes after Betadine application (all P values <.05). The Betadine significantly increased the Schein questionnaire score, compared both to baseline and the saline data, at the 1- and 4-hour visits (all P values <.05). Total corneal staining and the maximum NEI sector staining were significantly different from baseline and from the saline results at every visit (all P values <.05).
CONCLUSIONS: Betadine 5% application significantly decreases epithelial integrity of the cornea, decreases functional vision, and increases subjective complaints.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28609415     DOI: 10.1097/OPX.0000000000001091

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  8 in total

1.  Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study.

Authors:  Ellen Shorter; Meredith Whiteside; Jennifer Harthan; Mathew S Margolis; Andrew T Hartwick; Spencer Johnson; Mary Migneco; Christina Morettin; Christian K Olson; Julia Huecker; Tammy Than; Mae O Gordon
Journal:  Ocul Surf       Date:  2019-08-08       Impact factor: 5.033

2.  Letter to the Editor: Effect of Povidone Iodine 5% on the Cornea, Vision, and Subjective Comfort.

Authors:  Andrew Hartwick; Ellen Shorter; Mathew Margolis; Spencer Johnson; Tammy Than
Journal:  Optom Vis Sci       Date:  2017-11       Impact factor: 1.973

Review 3.  Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: a Review.

Authors:  Jason A Zehden; Xavier M Mortensen; Ashvini Reddy; Alice Yang Zhang
Journal:  Curr Diab Rep       Date:  2022-09-02       Impact factor: 5.430

4.  Povidone iodine treatment is deleterious to human ocular surface conjunctival cells in culture.

Authors:  William Swift; Jeffrey A Bair; Wanxue Chen; Michael Li; Sole Lie; Dayu Li; Menglu Yang; Marie A Shatos; Robin R Hodges; Miriam Kolko; Tor P Utheim; Wendell Scott; Darlene A Dartt
Journal:  BMJ Open Ophthalmol       Date:  2020-09-16

5.  Instillation of 5% Povidone-Iodine Ophthalmic Drops Decreases the Respiratory Rate in Children Undergoing Strabismus Surgery: A Randomized Controlled Trial.

Authors:  Michelle S Rovner; Bethany Jacobs Wolf; Melanie Rubin; Alexandra Ritter; Christopher L Heine; Tracy E Wester; Cory M Furse
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2019-11-01       Impact factor: 1.402

6.  Effects of Intravitreal Injection on Ocular Surface and Anterior Segment Parameters.

Authors:  Hafize Gokben Ulutas; Neslihan Parmak Yener
Journal:  Beyoglu Eye J       Date:  2021-06-08

7.  Hypochlorous acid antiseptic washout improves patient comfort after intravitreal injection: A patient reported outcomes study.

Authors:  Anthony Fam; Paul T Finger; Ankit S Tomar; Gaurav Garg; Kimberly J Chin
Journal:  Indian J Ophthalmol       Date:  2020-11       Impact factor: 1.848

Review 8.  Postoperative Endophthalmitis and Toxic Anterior Segment Syndrome Prophylaxis: 2020 Update.

Authors:  Jesse D Sengillo; Ying Chen; Diley Perez Garcia; Stephen G Schwartz; Andrzej Grzybowski; Harry W Flynn
Journal:  Ann Transl Med       Date:  2020-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.